Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Loxoprofen Sodium

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    LOXOPROFEN SODIUM HYDRATE

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 8Loxonin

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Loxonin

    Loxoprofen Sodium

    arrow
    RDD
    Not Confirmed

    Brand Name : Loxonin

    Japan
    arrow
    RDD
    Not Confirmed

    Daiichi Sankyo

    Loxoprofen Sodium

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 225

    2019 Revenue in Millions : 265

    Growth (%) : -15

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Loxonin

    Loxoprofen Sodium

    arrow
    RDD
    Not Confirmed

    Brand Name : Loxonin

    Japan
    arrow
    RDD
    Not Confirmed

    Daiichi Sankyo

    Loxoprofen Sodium

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 192

    2020 Revenue in Millions : 224

    Growth (%) : -8

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Loxonin

    Loxoprofen Sodium

    arrow
    RDD
    Not Confirmed

    Brand Name : Loxonin

    Japan
    arrow
    RDD
    Not Confirmed

    Daiichi Sankyo

    Loxoprofen Sodium

    Main Therapeutic Indication : Musculoskeletal

    Currency : USD

    2022 Revenue in Millions : 148

    2021 Revenue in Millions : 192

    Growth (%) : -23

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Loxonin

    Loxoprofen Sodium

    arrow
    RDD
    Not Confirmed

    Brand Name : Loxonin

    Japan
    arrow
    RDD
    Not Confirmed

    Daiichi Sankyo

    Loxoprofen Sodium

    Main Therapeutic Indication : Musculoskeletal

    Currency : USD

    2023 Revenue in Millions : 111

    2022 Revenue in Millions : 148

    Growth (%) : -16

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Loxonin

    Loxoprofen Sodium

    arrow
    RDD
    Not Confirmed

    Brand Name : Loxonin

    Japan
    arrow
    RDD
    Not Confirmed

    Daiichi Sankyo

    Loxoprofen Sodium

    Main Therapeutic Indication : Musculoskeletal

    Currency : USD

    2024 Revenue in Millions : 89

    2023 Revenue in Millions : 111

    Growth (%) : -19

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Loxonin

    Loxoprofen Sodium

    arrow
    RDD
    Not Confirmed

    Brand Name : Loxonin

    Japan
    arrow
    RDD
    Not Confirmed

    Daiichi Sankyo

    Loxoprofen Sodium

    Main Therapeutic Indication : Anti-inflammatory

    Currency : USD

    2017 Revenue in Millions : 376

    2016 Revenue in Millions : 356

    Growth (%) : 6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Loxonin

    Loxoprofen Sodium

    arrow
    RDD
    Not Confirmed

    Brand Name : Loxonin

    Japan
    arrow
    RDD
    Not Confirmed

    Daiichi Sankyo

    Loxoprofen Sodium

    Main Therapeutic Indication : Anti-Inflammatory

    Currency : USD

    2018 Revenue in Millions : 286

    2017 Revenue in Millions : 353

    Growth (%) : -19%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Loxonin

    Loxoprofen Sodium

    arrow
    RDD
    Not Confirmed

    Brand Name : Loxonin

    Japan
    arrow
    RDD
    Not Confirmed

    Daiichi Sankyo

    Loxoprofen Sodium

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2019 Revenue in Millions : 269

    2018 Revenue in Millions : 296

    Growth (%) : -9

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.